Drug interactions
Indacaterol-glycopyrronium + Rocuronium
Severity: Minor
Indacaterol-glycopyrronium and Rocuronium: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Rocuronium is a nondepolarizing neuromuscular blocker acting at nicotinic receptors, whereas glycopyrronium acts at muscarinic receptors. Clinically relevant additive effects are not expected with inhaled glycopyrronium. Beta2-agonists may modestly affect potassium, which can alter neuromuscular blockade.
What this interaction means in plain words
Indacaterol-glycopyrronium and Rocuronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Indacaterol-glycopyrronium belongs to Respiratory; Rocuronium belongs to Musculoskeletal.
Why it happens
No meaningful direct interaction; different receptor targets and low systemic glycopyrronium exposure.
What to do
No specific action is needed beyond routine neuromuscular monitoring during anesthesia. Check potassium if hypokalemia is suspected.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Rocuronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Rocuronium
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Rocuronium?
MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Rocuronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rocuronium is a nondepolarizing neuromuscular blocker acting at nicotinic receptors, whereas glycopyrronium acts at muscarinic receptors. Clinically relevant additive effects are not expected with inhaled glycopyrronium. Beta2-agonists may modestly affect potassium, which can alter neuromuscular blockade.
How serious is the interaction between Indacaterol-glycopyrronium and Rocuronium?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed beyond routine neuromuscular monitoring during anesthesia. Check potassium if hypokalemia is suspected.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
